NAII Natural Alternatives International Inc.

CarnoSyn® Brands Unveils TriBsyn™ - “The World’s First Paresthesia-Free Beta-Alanine Powder”

CarnoSyn® Brands Unveils TriBsyn™ - “The World’s First Paresthesia-Free Beta-Alanine Powder”

CARLSBAD, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Exclusively from Natural Alternatives International, Inc. (NAI), CarnoSyn® Brands portfolio of patented ingredients presents TriBsyn™, a groundbreaking new carnosine booster utilizing CarnoSyn® beta-alanine and patent-pending technology to increase beta-alanine bioavailability and absorption while effectively eliminating beta-alanine related paresthesia.

The proprietary TriBsyn™ formulation successfully removes the common paresthesia sensation associated with efficacious dosages of beta-alanine, creating a brand-new opportunity to reach untapped consumers from older adults to vegetarians and vegans.

Increased carnosine levels have been scientifically proven to provide a significant range of support for general wellness, including:

  • Bolstering cognitive performance and improving mental fatigue
  • Increasing both muscle function and quality in older adults
  • Slowing the process of age-related health and mental decline

In clinical trials, results showed the elimination of paresthesia and an increased pharmacokinetic efficiency, confirming TriBsyn’s™ enhanced delivery and exceptional bioavailability—improving the absorption of beta-alanine by more than four times compared to conventional beta-alanine. The increased efficiency allows for product formulations with significantly less beta-alanine, thereby improving formulation flexibility for various delivery systems.

“After extensive research and trials, we are proud to announce TriBsyn™, which contains CarnoSyn®, the only beta-alanine approved by the FDA under NDI status,” said Aaron Starr, Vice President, CarnoSyn® Brands. “With the innovation of a paresthesia-free beta-alanine, TriBsyn™ sets a new standard in beta-alanine supplementation, ensuring that users can experience the full range of health benefits without the paresthesia or ‘tingling’ often experienced as a side effect. We eagerly anticipate the commercial launch of TriBsyn™ at our first industry event in September, at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan, Italy.”

Ken Wolf, President of NAI shared, “TriBsyn’s™ launch will bolster our presence in a plethora of dietary supplement categories as well as fortified and medical foods. There is an evolving need and growing demand for healthy aging and wellness solutions—particularly for the aging population and those with plant-based diets. We look forward to sharing this revolutionary new product with our existing customers as well as creating a new customer following.”

To learn more about TriBsyn™ visit .

About CarnoSyn® Brands:

CarnoSyn® Brands feature three clinically studied, patented ingredients available exclusively from Natural Alternatives International, Inc.: CarnoSyn® instant release beta-alanine powder, SR CarnoSyn® sustained release beta-alanine tablets, and TriBsyn™ powder. In 2019, CarnoSyn® beta-alanine successfully obtained NDI status from the FDA and received Self-Affirmed GRAS (Generally Recognized as Safe) status. SR CarnoSyn®, an advanced delivery form of CarnoSyn®, received GRAS affirmation in 2017. The new “paresthesia-free” TriBsyn™ powder allows NAI to broaden their product offerings within the dietary supplement category, including medical and other fortified food products. To learn more about SR CarnoSyn® in active nutrition and wellness, visit . For more information about the latest innovation, TriBsyn™, visit .

About NAI:

NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI’s comprehensive partnership approach offers a wide range of innovative nutritional products and services to clients including scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. For more information about NAI, please visit .

Contact:

Renee Michaelson

Director of Global Marketing

NAI/CarnoSyn® Brands

(760) 736-7700



EN
07/08/2024

Underlying

Reports on Natural Alternatives International Inc.

 PRESS RELEASE

Natural Alternatives International, Inc. Announces New Manufacturing A...

Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (“NAI”) (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced it has extended its partnership with The Juice Plus+ Company (“Juice Plus+”), a globally recognized leader in plant-based whole-body nutritional products, through the execution of a new multi-year Manufacturing Agreement covering Juice Plus+ capsule and powder products sol...

 PRESS RELEASE

Natural Alternatives International, Inc. Announces Amended and Extende...

Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit facility with Wells Fargo Bank, NA (“Wells Fargo”). This amendment modifies the current facility extending the term of the agreement to December 31, 2026 and modifies the borrowing capacity to $10 million. Mark A. Le Doux, Chairm...

 PRESS RELEASE

Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Res...

Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results CARLSBAD, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.2 million, or $0.37 per diluted share, on net sales of $28.8 million for the third quarter of fiscal year 2025 compared to a net loss of $1.6 million, or $0.27 per diluted share, in the third quarter of the prior fiscal year. Net sales during the three months ended March 31, 2025, ...

 PRESS RELEASE

Natural Alternatives International and CarnoSyn® Brands Publish Clinic...

Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination CARLSBAD, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands today announced the publication of positive clinical trial results in the journal showing that TriBsyn™ supplementation led to significantly greater bioavailability and efficiency of beta-alanine along with the elimination of paresthesia, a common beta-alanine side effect. ...

 PRESS RELEASE

Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Res...

Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results CARLSBAD, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.2 million, or $0.37 per diluted share, on net sales of $34.1 million for the second quarter of fiscal year 2025 compared to a net loss of $3.1 million, or $0.52 per diluted share, in the second quarter of the prior fiscal year. Net sales during the three months ended December ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch